No Data
No Data
GRAIL to Announce First Quarter 2025 Financial Results
A Great Week for Institutional Investors Who Own 57% of GRAIL, Inc. (NASDAQ:GRAL)
New Analyst Forecast: $GRAL Given $32.0 Price Target
GRAIL to Present New Data on Galleri and Its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence
CCORF Initiates Grail(GRAL.US) With Buy Rating, Announces Target Price $32